A Study of Risdiplam in Infants With Genetically Diagnosed and Presymptomatic Spinal Muscular Atrophy
Clinical trial NCT03779334 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03779334
- Sponsor
- Hoffmann-La Roche
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-07
- Primary completion
- 2023-02-20
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.